● Recruiting

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

Condition: IC-MPGN · Sponsor: Novartis Pharmaceuticals

PhasePhase 3

Planned participants106

Who can joinAll sexes, 12 Years to 60 Years

Healthy volunteersNo

About this study

This study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in idiopathic immune complex mediated membranoproliferative glomerulonephritis.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals · 1-888-669-6682 · novartis.email@novartis.com

Novartis Pharmaceuticals · +41613241111

Always discuss trial participation with your own doctor first.

Locations (131)

Ronald Reagan UCLA Medical Center	Los Angeles, California, United States	Recruiting
Univ Cali Irvine ALS Neuromuscular	Orange, California, United States	Recruiting
UCSF	San Francisco, California, United States	Recruiting
Olive View UCLA Medical Center	Sylmar, California, United States	Recruiting
Childrens Hospital Colorado	Aurora, Colorado, United States	Recruiting
Nicklaus Childrens Hospital	Miami, Florida, United States	Recruiting
Emory University School of Medicine-Winship Cancer Institute	Atlanta, Georgia, United States	Recruiting
Massachusetts General Hospital	Boston, Massachusetts, United States	Recruiting
Boston Univ School of Medicine	Boston, Massachusetts, United States	Recruiting
University of Minnesota	Minneapolis, Minnesota, United States	Recruiting
Washington University in St Louis	St Louis, Missouri, United States	Recruiting
University of New Mexico	Albuquerque, New Mexico, United States	Recruiting

+ 119 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05755386